Withdrawal of Approval of New Animal Drug Applications; Carbarsone; Roxarsone

摘要

The Food and Drug Administration (FDA) is withdrawing approval of three new animal drug applications (NADAs) for roxarsone or carbarsone Type A medicated articles at the sponsor's request because the products are no longer manufactured or marketed.